Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/CE

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year EV/CE History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/CE(x) 3.982.981.180.961.18

What is the latest EV/CE ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/CE ratio of GLENMARK PHARMACEUTICALS is 3.98 based on Mar2025 Consolidated results.
Year EV/CE
Mar20253.98
Mar20242.98
Mar20231.18
Mar20220.96
Mar20211.18

How is EV/CE of GLENMARK PHARMACEUTICALS Trending?

Years EV/CE % Change
Mar2025 3.98
33.56
Mar2024 2.98
152.54
Mar2023 1.18
22.92
Mar2022 0.96
-18.64
Mar2021 1.18 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/CE ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹54,728.5 Cr -3.1% -4.7% 43.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,341.0 Cr -1.8% -6.4% -10.7% Stock Analytics
DIVIS LABORATORIES ₹160,401.0 Cr -0.3% -5.5% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,175.0 Cr -0.1% 4% 18.7% Stock Analytics
CIPLA ₹107,100.0 Cr 1% -12.3% -5.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,715.9 Cr -4.6% -7% 1.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-3.1%

-4.7%

43.9%

SENSEX

-1%

-4.7%

6%


You may also like the below Video Courses